top of page
.png){kind=small}
Living with COPD?
Who can participate?
You may qualify if you:
-
Are between 40 to 80 years old
-
Have been diagnosed with COPD
-
Are not currently taking medications for COPD, or are only using rescue medications, or taking LABA/ICS medications
Study Timeline
-
A 7- to 14-day screening period
-
A 28-day treatment period
-
A 7-day follow-up visit
About the Study
The purpose of this study is to evaluate how the body responds to the combination of ensifentrine and glycopyrrolate, both together and individually. The study medication is administered as an inhaled treatment and may help open the airways and reduce inflammation in the lungs.
bottom of page